View of Directness and quality of evidence of bevacizumab combined with chemotherapy for platinum-resistant, recurrent ovarian cancer in the AURELIA trial

Return to Article Details Directness and quality of evidence of bevacizumab combined with chemotherapy for platinum-resistant, recurrent ovarian cancer in the AURELIA trial Download Download PDF